Healthcare Services

Gastroretentive Drug Delivery Systems Outsourcing Market Expected to Record Steady Growth and Approach $2.1 Billion by 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Gastroretentive Drug Delivery Systems Outsourcing Market By 2030 Starting From Its 2026 Size?

The market size for gastroretentive drug delivery systems outsourcing has shown substantial growth over recent years. It is anticipated to increase from $1.49 billion in 2025 to $1.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. This historical expansion can be primarily attributed to factors like the limitations of conventional oral drug delivery, the rise in CRO services, the necessity for improved drug absorption, the broadening of the pharmaceutical pipeline, and advancements in formulation technology.

The gastroretentive drug delivery systems outsourcing market is projected to experience substantial expansion in the coming years. This market is forecast to reach $2.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. Key factors driving this growth during the forecast period include a rise in complex drug molecules, a greater need for patient-focused delivery systems, the broadening of outsourcing approaches, advancements in gastroretentive technologies, and pharmaceutical companies’ efforts towards cost optimization. Significant trends anticipated in this period encompass the increasing outsourcing of sophisticated drug delivery development, a heightened requirement for formulations with extended GI retention, the growing uptake of floating drug delivery systems, an increase in CRO collaborations for formulation development, and an emphasis on improving drug bioavailability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What Primary Drivers Are Shaping The Development Of The Gastroretentive Drug Delivery Systems Outsourcing Market?

The rising occurrence of gastrointestinal disorders is projected to propel the expansion of the gastroretentive drug delivery systems outsourcing market in the future. Gastrointestinal disorders refer to a diverse range of conditions impacting the digestive tract, including organs such as the stomach, liver, gallbladder, intestines, and pancreas. These disorders are increasing due to factors like aging populations, antibiotic use, infectious agents, dietary shifts, stress, lifestyle habits, and obesity. Outsourcing gastroretentive drug delivery systems equips pharmaceutical companies with the necessary resources and expertise to manage the growing burden of gastrointestinal disorders, ultimately enhancing patient outcomes and their quality of life. For instance, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government-funded research institute and public health agency, reported that 60 to 70 million people were affected by all digestive diseases. Consequently, the increasing prevalence of gastrointestinal disorders is a key driver for the gastroretentive drug delivery systems outsourcing market. The growing prevalence of age-related disorders is anticipated to fuel the growth of gastroretentive drug delivery systems in the future. Age-related disorders encompass a broad spectrum of medical conditions and functional impairments that predominantly affect older adults, such as cardiovascular diseases, neurodegenerative disorders, musculoskeletal conditions, and sensory impairments. The incidence of these disorders is increasing due to an aging global population, longer life expectancy, various lifestyle factors, and the accumulation of chronic diseases over time. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, reported that in 2023, approximately 194 million American adults, including 6 in 10 young adults, 8 in 10 midlife adults, and 9 in 10 older adults, had reported one or more medical conditions. Furthermore, the prevalence of chronic conditions saw an increase of 7.0 percentage points among young adults. Therefore, the increasing prevalence of age-related disorders is driving the gastroretentive drug delivery systems outsourcing market.

Which Segment Categories Define The Gastroretentive Drug Delivery Systems Outsourcing Market?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Floating Systems: Single Unit Systems, Multiple Unit Systems

2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

How Are Trends Impacting The Gastroretentive Drug Delivery Systems Outsourcing Market?

Companies actively engaged in the gastroretentive drug delivery systems outsourcing market are prioritizing the creation of innovative products, such as ready-to-fill (RTF) colon functional capsules, to boost drug delivery efficiency and patient convenience. These ready-to-fill (RTF) colon functional capsules are pre-manufactured, empty capsules meant to be filled with specific formulations or active ingredients tailored for the colon. As an illustration, in September 2024, Evonik, an advanced drug delivery provider from Germany, launched EUDRACAP colon functional capsules, specifically designed for the targeted administration of oral drugs to the ileo-colonic region. These groundbreaking capsules are the first ready-to-fill alternative available in the market, intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently offered as technical grade, a GMP-grade product is also being developed. EUDRACAP colon streamlines the oral drug development process by simplifying formulation and expediting time to market, signifying a major advance in gastroretentive drug delivery systems.

Who Are The Top Companies Competing In The Gastroretentive Drug Delivery Systems Outsourcing Market?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Read the full gastroretentive drug delivery systems outsourcing market report here:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

How Does The Gastroretentive Drug Delivery Systems Outsourcing Market Perform Across Major Global Regions?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastroretentive Drug Delivery Systems Outsourcing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2026, By The Business Research Company

Gastroparesis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Diabetic Gastroparesis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Gastric Volvulus Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795